Genetic Diseases | Medical XPRT
Articles & Whitepapers
-
Unleashing the Potential of Recombinant Adeno-Associated Virus (rAAV) Particles in Gene Therapy
Recombinase Adeno-Associated Virus (rAAV) particles have taken the center-stage in gene therapy research and development due to their exceptional genetic manipulation capabilities, safety and unprecedented therapeutic success. As biomedical science advances, there is an ever-increasing enthusiasm in the usage of rAAV particles as effective vehicles for gene delivery and the subsequent therapy. ...
-
Unveiling the Intricacies of DNM1L: Function, Associated Diseases, and Inheritance Patterns
Introduction The human body is a complex network of genes and proteins, each playing a crucial role in maintaining our health. One such gene, DNM1L, has garnered significant attention in recent years ...
News
-
Comprehensive Gene Therapy Development Solutions to Further Boost Rare Disease Research
As several gene therapy approvals for rare disease treatment gain steam in 2023, a comprehensive set of gene therapy development solutions is released to pave richer avenues for rare disease research. This path-breaking move sees the integration of ...
Advances in Newborn SMA Screening research by SNP Biotechnology
CD Genomics Launches Advanced Whole Exome Sequencing Service, Empowering Genetic Research
Bayer strengthens gene therapy portfolio with lipid nanoparticle technology from Acuitas Therapeutics
CD Genomics Unveils Advanced Mitochondrial Diseases Panel Sequencing Service
Equipment & Solutions
-
Showcase
Stem Cells & Regenerative Medicine
Regenerative Medicine refers to innovative therapies aimed at the permanent restoration of diseased tissues and organs. Tissue integrity and regeneration depend on a population of self-renewing somatic stem cells, above all in constantly renewing tissues.